
In humans, the zzso zzso comprise a family of three zzso zzso zzso zzso and zzso zzso is zzso from a biologically inactive zzso Big zzso by an unusual zzso of the zzso zzso bond by the zzso converting zzso zzso In humans, there are four zzso zzso derived from a single gene by the action of alternative zzso zzso they differ only in the zzso acid sequence of the extreme zzso A second zzso zzso also exists as four zzso and differs from zzso in requiring an zzso pH for optimal zzso Human zzso can also cleave Big zzso to zzso which is zzso in turn, to the mature zzso as an alternative zzso zzso is the principal zzso in the human cardiovascular system and remains one of the most potent zzso of human vessels zzso zzso is unusual in being released from a dual zzso zzso The zzso is continuously released from vascular zzso cells by the zzso pathway, producing intense zzso of the underlying smooth muscle and contributing to the maintenance of zzso vascular zzso zzso is also released from zzso zzso storage zzso zzso zzso in response to external zzso zzso mediate their action by zzso two G zzso zzso zzso ETA and zzso Two therapeutic strategies have emerged to oppose the actions of zzso namely zzso of the synthetic zzso by combined zzso zzso zzso such as zzso and zzso zzso such as zzso The zzso system is zzso in zzso and zzso zzso may be of benefit in reducing blood pressure in essential zzso zzso the first zzso zzso approved for clinical use, represents a significant new therapeutic strategy in the treatment of pulmonary zzso hypertension zzso 

